Pilihan
Jenfi Surpasses US$100 Million in SME Financing Across Southeast Asia
SINGAPORE, May 19, 2026 (GLOBE NEWSWIRE) -- Jenfi, a Southeast Asia-focused SME credit platform, today announced that it has surpassed US$100 million in cumulative financing originations across the region, marking a significant milestone in the company's continued expansion across Singapore and Vietnam.
Operating across two of Southeast Asia's largest SME markets, Jenfi provides growth financing and working capital solutions to underserved businesses through a combination of proprietary underwriting infrastructure, alternative data, and institutional capital partnerships.
Since inception, Jenfi has evaluated more than 30,000 SME financing inquiries across Southeast Asia while continuing to expand its underwriting and portfolio monitoring infrastructure to support scalable credit deployment and faster financing turnaround times.
Over time, Jenfi has evolved beyond its initial revenue-based financing roots into a broader SME credit platform supporting multiple financing structures across growth, working capital, and supply-chain financing use cases.
Jenfi continues to invest in AI-assisted underwriting automation and operational infrastructure designed to improve capital efficiency and credit decisioning capabilities. The platform is currently able to provide same-day underwriting decisions for qualified applicants and maintains a portfolio generating gross IRRs above 40%.
The company has completed more than 2,400 financings across Southeast Asia and has historically experienced strong repeat utilization behavior among eligible borrowers, reflecting ongoing demand for flexible financing solutions across its core markets.
"Southeast Asia continues to face a significant SME credit gap, particularly for businesses underserved by traditional collateral-based lending," said Jeffrey Liu, Founder and CEO of Jenfi.
"Crossing the US$100 million milestone reflects the underwriting infrastructure, operational discipline, and institutional partnerships we have built over time. We believe there is a substantial opportunity to continue building more scalable underwriting and financing infrastructure for underserved SMEs across Southeast Asia."
Looking ahead, Jenfi plans to continue expanding its institutional funding relationships, embedded financing capabilities, and underwriting infrastructure as it continues building a broader SME credit platform for Southeast Asia.
About Jenfi
Jenfi is a Southeast Asia-focused SME credit platform building underwriting and financing infrastructure for underserved businesses across the region. Operating across Singapore and Vietnam, the company combines proprietary credit models, alternative data, and institutional capital partnerships to deliver scalable growth and working capital solutions to emerging SMEs.
Media Contact
Jenfi
press@jenfi.com
https://www.jenfi.com
Copyright 2026 GlobeNewswire, Inc.
.png)

Berita Lainnya
ANTGAMER Joins Saroasis’ Fate Trigger at 2026 Hong Kong Spring Electronics Fair as HKC Showcases Advanced Display Technologies
Bitget Cuts Futures Trading Fees to Deepen Liquidity Amidst the Tokenization Boom
Scientists and explorers unite at the Yacht Club de Monaco for 'A Day of Exploration'
HERE Technologies dan MengQing memperluas penerapan navigasi cerdas untuk produsen kendaraan komersial terkemuka di Tiongkok.
TabTrade Becomes FirstBroker to Integrate With TradePoints, Introducing a Loyalty Rewards Program for Forex Traders
Copenhagen Infrastructure Partners completes acquisition of Ørsted’s European onshore platform – and launches Perigus Energy
Omni Bridgeway Mengangkat Peter Galgay sebagai Head of Commercial Strategy and Capital Solutions
Tech-Driven Restoration: Saving the World's Critically Endangered White-headed Langur
Verisk Estimates Economic Losses From June 24 Venezuela Earthquake Sequence Will Exceed USD 10 Billion
Univar Solutions Memperluas Kemitraan Eksklusif dengan American Distilling untuk Bahan Baku Produk Kecantikan, Perawatan Pribadi, dan Farmasi di EMEA
Italpreziosi Achieves LMBA Silver Good Delivery Accreditation
Beamion LUNG - 1 study results for zongertinib in treatment-naive patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine